A new pain reliever that uses marijuana extracts can be prescribed in Britain, the government said this week. Under the new policy, the drug Sativex can be given to multiple sclerosis patients to relieve pain and spasms. For now, British patients must import their Sativex from Canada. But GW Pharmaceuticals, the company that makes Sativex, has been given a license to cultivate pot in the U.K. and plans to open a factory there. The plants are already being grown at a secret location somewhere in England.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Will Israel have indefinite control of Gaza?
Today's Big Question Netanyahu's newly unveiled plan for the 'day after' the war with Hamas raises the prospect of a permanent military presence in the Palestinian territory
By Rafi Schwartz, The Week US Published
Is Google's new AI bot 'woke'?
Talking Points Gemini produced images of female popes and Black Vikings. Now the company has stepped back.
By Joel Mathis, The Week US Published
How do tax deductions really work?
The Explainer Writing off an expense may seem like an easy way to put money back in your pocket — but it is a little more complicated than that
By Becca Stanek, The Week US Published